NCT01978912View on ClinicalTrials.gov

A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 16, 2018

Study Completion Date

October 16, 2018

Conditions

Lumbar Disc Herniation

Interventions

DRUG

KTP-001

KTP-001 is one time dose intradiscally.

Trial Locations (10)

30322

Emory University, Atlanta

32806

Compass Research, LLC, Orlando

35235

Alabama Clinical Therapeutics, LLC, Birmingham

40509

Central Kentucky Research Associates, Inc., Lexington

48073

William Beaumont Hospital, Royal Oak

60612

Rush University Medical Center, Chicago

60657

Chicago Anesthesia Pain Specialists, Chicago

85018

HOPE Research Institute, LLC, Phoenix

92024

CORE Orthopaedic Medical Center, Encinitas

94115

California Spine Diagnostic, San Francisco

All Listed Sponsors

lead

Teijin America, Inc.

INDUSTRY

NCT01978912 - A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation | Biotech Hunter | Biotech Hunter